Filter News
Area of Research
- (-) Fusion and Fission (1)
- (-) National Security (3)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (1)
- Biology and Environment (1)
- Clean Energy (15)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Isotopes (11)
- Materials (17)
- Materials for Computing (4)
- Neutron Science (2)
- Sensors and Controls (1)
- Supercomputing (4)
News Topics
- (-) Cybersecurity (3)
- (-) Isotopes (2)
- (-) Microscopy (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (3)
- Artificial Intelligence (1)
- Biology (1)
- Biomedical (1)
- Chemical Sciences (1)
- Computer Science (4)
- Energy Storage (1)
- Environment (2)
- Fusion (8)
- High-Performance Computing (1)
- ITER (4)
- Materials (1)
- Materials Science (2)
- Molten Salt (3)
- Nanotechnology (1)
- National Security (4)
- Neutron Science (2)
- Nuclear Energy (9)
- Quantum Science (1)
- Security (3)
- Sustainable Energy (1)
- Transportation (2)
Media Contacts
A team of collaborators from ORNL, Google Inc., Snowflake Inc. and Ververica GmbH has tested a computing concept that could help speed up real-time processing of data that stream on mobile and other electronic devices.
ORNL's Larry Baylor and Andrew Lupini have been elected fellows of the American Physical Society.
Oak Ridge National Laboratory researchers have created a technology that more realistically emulates user activities to improve cyber testbeds and ultimately prevent cyberattacks.
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.